These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 19101912

  • 1. Graft fibrosis after pediatric liver transplantation: ten years of follow-up.
    Scheenstra R, Peeters PM, Verkade HJ, Gouw AS.
    Hepatology; 2009 Mar; 49(3):880-6. PubMed ID: 19101912
    [Abstract] [Full Text] [Related]

  • 2. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

  • 3. Graft fibrosis in stable pediatric liver transplant recipients: what does it mean?
    Magee JC.
    Hepatology; 2009 Mar; 49(3):726-8. PubMed ID: 19241487
    [No Abstract] [Full Text] [Related]

  • 4. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.
    Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S.
    Transplantation; 2009 Feb 27; 87(4):606-14. PubMed ID: 19307800
    [Abstract] [Full Text] [Related]

  • 5. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J.
    Liver Transpl; 2003 Nov 27; 9(11):1152-8. PubMed ID: 14586875
    [Abstract] [Full Text] [Related]

  • 6. Progressive histological damage in liver allografts following pediatric liver transplantation.
    Evans HM, Kelly DA, McKiernan PJ, Hübscher S.
    Hepatology; 2006 May 27; 43(5):1109-17. PubMed ID: 16628633
    [Abstract] [Full Text] [Related]

  • 7. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan 27; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 8. Liver allograft pathology in healthy pediatric liver transplant recipients.
    Briem-Richter A, Ganschow R, Sornsakrin M, Brinkert F, Schirmer J, Schaefer H, Grabhorn E.
    Pediatr Transplant; 2013 Sep 27; 17(6):543-9. PubMed ID: 23834615
    [Abstract] [Full Text] [Related]

  • 9. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M, Rayón JM, Prieto M, Aguilera V, Nicolás D, Ortiz V, Carrasco D, López-Andujar R, Mir J, Berenguer J.
    Liver Transpl; 2001 Sep 27; 7(9):790-6. PubMed ID: 11552213
    [Abstract] [Full Text] [Related]

  • 10. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S, Lampela H, Jalanko H, Mäkisalo H, Lohi J, Arola J, Pakarinen MP.
    Liver Transpl; 2013 Feb 27; 19(2):145-54. PubMed ID: 23109058
    [Abstract] [Full Text] [Related]

  • 11. Graft histology characteristics in long-term survivors of pediatric liver transplantation.
    Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM.
    Liver Transpl; 2008 Nov 27; 14(11):1582-7. PubMed ID: 18975292
    [Abstract] [Full Text] [Related]

  • 12. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.
    Liver Transpl; 2004 Oct 27; 10(10):1240-7. PubMed ID: 15376304
    [Abstract] [Full Text] [Related]

  • 13. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 27; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 14. Unique clinical conditions associated with different acinar regions of fibrosis in long-term surviving pediatric liver grafts.
    Baas M, Gouw ASH, van den Heuvel MC, Hepkema BG, Peeters PMGJ, Verkade H, Scheenstra R.
    Pediatr Transplant; 2017 Nov 27; 21(7):. PubMed ID: 28627016
    [Abstract] [Full Text] [Related]

  • 15. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.
    Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091
    [Abstract] [Full Text] [Related]

  • 16. Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis.
    Manzia TM, Toti L, Angelico R, Di Cocco P, Orlando G, Tisone G.
    Transplant Proc; 2010 May 15; 42(4):1237-9. PubMed ID: 20534270
    [Abstract] [Full Text] [Related]

  • 17. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
    Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G.
    Transpl Int; 2013 Mar 15; 26(3):259-66. PubMed ID: 23278973
    [Abstract] [Full Text] [Related]

  • 18. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov 15; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 19. Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation.
    Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T.
    Liver Transpl; 2005 May 15; 11(5):547-54. PubMed ID: 15838883
    [Abstract] [Full Text] [Related]

  • 20. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK.
    JAMA; 2012 Jan 18; 307(3):283-93. PubMed ID: 22253395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.